Literature DB >> 786296

Characteristics of patients with serum antibodies to extractable nuclear antigens.

J H Leibfarth, R H Persellin.   

Abstract

A distinguishing feature of the mixed connective tissue disease (MCTD) syndrome is the presence in the serum of antibody in high titer to ribonucleoprotein (RNP). To determine whether this was an exclusive observation, a large rheumatic disease population was surveyed for the presence of antibody in high titer to extractable nuclear antigens (ENA) including RNP. Of 650 sera examined, 440 (from 240 patients) had antinuclear antibody. Only 39 patients had serum antibody to ENA in titers greater than or equal to 1:200 dilution. In 16 the anti-ENA was shown by RNAse digestion to be anti-RNP. Although many clinical and laboratory characteristics were similar in these two groups, the patients more closely resembled the previously described MCTD syndrome and, importantly, less often had severe renal and central nervous system disease manifestations. Thus the presence of serum antibodies to ENA that are predominantly RNAse-sensitive (anti-RNP) helps to identify a rheumatic disease syndrome and also appears to have prognostic value.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786296     DOI: 10.1002/art.1780190503

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases.

Authors:  M Abu-Shakra; M Krup; H Slor; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 2.  Antinucleic acid antibodies.

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

3.  The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies.

Authors:  M Abu-Shakrah; M Krupp; S Argov; D Buskila; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

Review 4.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).

Authors:  A Gaudreau; B Amor; M F Kahn; A Ryckewaert; J Sany; A P Peltier
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

6.  Clinical significance of antibodies to ribonucleoprotein.

Authors:  M L Cohen; B Dawkins; R L Dawkins; E T Owen
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

7.  Prospective analysis of antiribonucleoprotein antibodies in systemic lupus erythematosus.

Authors:  B Bresnihan; R Grigor; G R Hughes
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease.

Authors:  E Genth; H Zarnowski; R Mierau; D Wohltmann; P W Hartl
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

9.  In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.

Authors:  J V Wells; J Webb; M Van Deventer; B Fry; K M Pollard; J Raftos; W Monk; D S Nelson
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

10.  Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.

Authors:  J Calderon; V Rodriguez-Valverde; S Sanchez Andrade; J L Riestra; J Gomez-Reyno
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.